Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myasthenia Gravis Generalized”

129 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 129 results

Large-scale testing (Phase 3)Study completedNCT05039190
What this trial is testing

Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG Patients

Who this might be right for
Myasthenia Gravis
Harbour BioMed (Guangzhou) Co. Ltd. 132
Not applicableLooking for participantsNCT06967480
What this trial is testing

Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia GravisAnti-AChR Antibody Positive
Alexion Pharmaceuticals, Inc. 40
Large-scale testing (Phase 3)Looking for participantsNCT06055959
What this trial is testing

Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
UCB Biopharma SRL 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07372807
What this trial is testing

Ripertamab for the Treatment of Myasthenia Gravis

Who this might be right for
Myasthenia Gravis (MG)
Zhongming Qiu 20
Testing effectiveness (Phase 2)Looking for participantsNCT07284420
What this trial is testing

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

Who this might be right for
AChR-Ab Seropositive Generalized Myasthenia GravisMyasthenia GravisMG+3 more
argenx 70
Large-scale testing (Phase 3)Study completedNCT04650854
What this trial is testing

Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
UCB Biopharma SRL 165
Not applicableEnrolling By InvitationNCT06877403
What this trial is testing

Prevalence and Impact of Fatigue in Myasthenic Patients Followed At Clermont-Ferrand University Hospital - "My" Asthenia

Who this might be right for
Myasthenia Gravis
University Hospital, Clermont-Ferrand 100
Large-scale testing (Phase 3)Looking for participantsNCT05265273
What this trial is testing

Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Janssen Research & Development, LLC 12
Large-scale testing (Phase 3)Ended earlyNCT05132569
What this trial is testing

Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Sanofi 6
Not applicableWithdrawnNCT04224506
What this trial is testing

A Pilot Study to Explore the Role of Gut Flora in Myasthenia Gravis

Who this might be right for
Myasthenia GravisMyasthenia Gravis, Generalized
ProgenaBiome
Large-scale testing (Phase 3)Looking for participantsNCT06463587
What this trial is testing

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

Who this might be right for
Generalized Myasthenia Gravis
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 264
Post-approval studies (Phase 4)Looking for participantsNCT07246564
What this trial is testing

Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
UCB Biopharma SRL 40
Testing effectiveness (Phase 2)Study completedNCT02565576
What this trial is testing

Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Generalized
Novartis Pharmaceuticals 44
Early research (Phase 1)Looking for participantsNCT06626919
What this trial is testing

Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

Who this might be right for
Muscular DiseasesNeuromuscular ManifestationsAutoimmune+4 more
Arcellx, Inc. 30
Testing effectiveness (Phase 2)Looking for participantsNCT07501702
What this trial is testing

Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Generalized
Vertex Pharmaceuticals Incorporated 30
Large-scale testing (Phase 3)Study completedNCT00683969
What this trial is testing

Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Generalized
Hoffmann-La Roche 136
Very early researchLooking for participantsNCT07058298
What this trial is testing

GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103)

Who this might be right for
Generalized Myasthenia Gravis (gMG)
Daishi Tian 6
Large-scale testing (Phase 3)Active Not RecruitingNCT05070858
What this trial is testing

Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
Regeneron Pharmaceuticals 288
Post-approval studies (Phase 4)Looking for participantsNCT07072988
What this trial is testing

Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod

Who this might be right for
Myasthenia Gravis, Generalized
Centre Hospitalier Universitaire de Nice 50
Large-scale testing (Phase 3)Active Not RecruitingNCT05403541
What this trial is testing

Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
Immunovant Sciences GmbH 240
Load More Results